These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4664871)

  • 21. Cholera vaccine will reduce antibiotic use.
    Okeke IN
    Science; 2009 Aug; 325(5941):674. PubMed ID: 19661401
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiological aspects of an El Tor cholera outbreak in Kaduna, Nigeria.
    Hunponu-Wusu OO
    Trop Geogr Med; 1973 Sep; 25(3):277-81. PubMed ID: 4752245
    [No Abstract]   [Full Text] [Related]  

  • 23. [An update on cholera infection].
    Israil A
    Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):185-94. PubMed ID: 9932009
    [No Abstract]   [Full Text] [Related]  

  • 24. [Epidemiologic and prophylactic deductions in the bacteriologic studies of strains of Vibrio cholerae (O:1) isolated in Rwanda].
    De Pina JJ; Rault JP; Boutin JP; Niel L; Dodin A; Martet G
    Med Trop (Mars); 1994; 54(3):277. PubMed ID: 7885213
    [No Abstract]   [Full Text] [Related]  

  • 25. The aquatic environment as a reservoir of Vibrio cholerae: a review.
    Islam MS; Drasar BS; Sack RB
    J Diarrhoeal Dis Res; 1993 Dec; 11(4):197-206. PubMed ID: 8188990
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholera situation in the Americas, 1996.
    Epidemiol Bull; 1997 Mar; 18(1):5-10. PubMed ID: 9197083
    [No Abstract]   [Full Text] [Related]  

  • 27. Benefit versus risk factors in cholera and typhoid immunization.
    Joó I
    Dev Biol Stand; 1979; 43():47-52. PubMed ID: 520686
    [No Abstract]   [Full Text] [Related]  

  • 28. Present and future cholera vaccines.
    Olsson L; Parment PA
    Expert Rev Vaccines; 2006 Dec; 5(6):751-2. PubMed ID: 17184213
    [No Abstract]   [Full Text] [Related]  

  • 29. Haiti in the context of the current global cholera pandemic.
    Ryan ET
    Emerg Infect Dis; 2011 Nov; 17(11):2175-6. PubMed ID: 22204041
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-O1 Vibrio cholerae and epidemic cholera.
    Commun Dis Rep CDR Wkly; 1993 Jun; 3(24):107. PubMed ID: 7693194
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperinfectivity in cholera: a new mechanism for an old epidemiological model?
    Pascual M; Koelle K; Dobson AP
    PLoS Med; 2006 Jun; 3(6):e280. PubMed ID: 16789802
    [No Abstract]   [Full Text] [Related]  

  • 32. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral cholera vaccine campaign among internally displaced persons in South Sudan.
    Wkly Epidemiol Rec; 2014 May; 89(20):214-20. PubMed ID: 24864347
    [No Abstract]   [Full Text] [Related]  

  • 34. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
    Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outbreaks of cholera in Nepal.
    Pokhrel BM; Kubo T
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):574-9. PubMed ID: 9185273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholera, 2007.
    Wkly Epidemiol Rec; 2008 Aug; 83(31):269-83. PubMed ID: 18668979
    [No Abstract]   [Full Text] [Related]  

  • 37. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 38. Probable role of blue-green algae in maintaining endemicity and seasonality of cholera in Bangladesh: a hypothesis.
    Islam MS; Drasar BS; Sack RB
    J Diarrhoeal Dis Res; 1994 Dec; 12(4):245-56. PubMed ID: 7751564
    [No Abstract]   [Full Text] [Related]  

  • 39. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual occurrence of cholera in Delhi during January 1994: epidemiological investigations.
    Singh J; Khanna KK; Dhariwal AC; Bhattacharjee J; Singh M; Jain DC; Datta KK
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):107-9. PubMed ID: 8870404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.